Literature DB >> 17344789

Oyster mushroom reduced blood glucose and cholesterol in diabetic subjects.

K Khatun1, H Mahtab, P A Khanam, M A Sayeed, K A Khan.   

Abstract

It has been postulated that mushroom has beneficial effect of lowering blood glucose and cholesterol in diabetic subjects. The literature so far searched and found that there was no published data in this regard. This study was undertaken to assess the effect of reducing blood glucose, cholesterol and triglycerides in diabetic patients. Additionally, this study addressed whether there was any hepatic and renal toxicity of mushroom. This clinical investigation was conducted in BIRDEM hospital from July 2005 to January 2006. Eighty-nine subjects were recruited. Baseline investigations included height, weight, blood pressure (SBP, DBP), plasma glucose for fasting (FPG) and 2-h after-breakfast (2hPG), total cholesterol (T-chol), triglycerides (TG) and high-density lipoprotein (HDL-c). Twenty- four days' study constitutes 7-days mushroom, 7-days no mushroom and then 7-days mushroom. Investigations were done at the start and each after every 7-days. Thirty subjects (M / F = 17 / 13) followed to ensure full compliance with the designed protocol for 24 days. The mean (SD) age of the participants was 46.3 (10) years. Mushroom significantly reduced systolic and diastolic blood pressure (SBP, p<0.01; DBP, p<0.05). It also lowered both plasma glucose significantly (FPG & 2-hPG, p<0.001). Mushroom also lowered total cholesterol and TG significantly; whereas, there was no significant change in weight and HDL-c. When mushroom was withdrawn, there were significant increases of DBP, FPG, 2hPG, T-cholesterol and TG, whereas, no significant change was observed in weight, SBP and HDL-c. Restarting mushroom there was again significant reduction of blood glucose, TG and cholesterol. We conclude that mushroom significantly reduced blood glucose, blood pressure, TG and cholesterol of diabetic subjects without any deleterious effect on liver and kidney. The effect of mushroom may be investigated in a large sample for a longer duration to evaluate its efficacy and toxicity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17344789     DOI: 10.3329/mmj.v16i1.261

Source DB:  PubMed          Journal:  Mymensingh Med J        ISSN: 1022-4742


  13 in total

1.  Hypolipidemic effect of the edible mushroom Agaricus blazei in rats subjected to a hypercholesterolemic diet.

Authors:  Aline M de Miranda; Gustavo M Ribeiro; Aureliano C Cunha; Lorena S Silva; Rinaldo C dos Santos; Maria Lúcia Pedrosa; Marcelo E Silva
Journal:  J Physiol Biochem       Date:  2013-11-08       Impact factor: 4.158

2.  Modulation of human intestinal microbiota in a clinical trial by consumption of a β-D-glucan-enriched extract obtained from Lentinula edodes.

Authors:  Diego Morales; Sudarshan A Shetty; Bricia López-Plaza; Carmen Gómez-Candela; Hauke Smidt; Francisco Ramón Marín; Cristina Soler-Rivas
Journal:  Eur J Nutr       Date:  2021-02-12       Impact factor: 5.614

3.  Medicinal mushrooms: Towards a new horizon.

Authors:  A Ganeshpurkar; G Rai; A P Jain
Journal:  Pharmacogn Rev       Date:  2010-07

4.  Enhancement of the Th1-phenotype immune system by the intake of Oyster mushroom (Tamogitake) extract in a double-blind, placebo-controlled study.

Authors:  Aiko Tanaka; Mie Nishimura; Yuji Sato; Hiroki Sato; Jun Nishihira
Journal:  J Tradit Complement Med       Date:  2015-12-29

5.  Yield, size, nutritional value, and antioxidant activity of oyster mushrooms grown on perilla stalks.

Authors:  Huizhen Li; Zhijun Zhang; Mengxue Li; Xiaojun Li; Ziwen Sun
Journal:  Saudi J Biol Sci       Date:  2015-10-08       Impact factor: 4.219

Review 6.  Effect of the Intake of Oyster Mushrooms (Pleurotus ostreatus) on Cardiometabolic Parameters-A Systematic Review of Clinical Trials.

Authors:  Lisa Dicks; Sabine Ellinger
Journal:  Nutrients       Date:  2020-04-17       Impact factor: 5.717

Review 7.  Factors affecting mushroom Pleurotus spp.

Authors:  Marcelo Barba Bellettini; Fernanda Assumpção Fiorda; Helayne Aparecida Maieves; Gerson Lopes Teixeira; Suelen Ávila; Polyanna Silveira Hornung; Agenor Maccari Júnior; Rosemary Hoffmann Ribani
Journal:  Saudi J Biol Sci       Date:  2016-12-18       Impact factor: 4.219

8.  Oyster mushroom functions as an anti-hyperglycaemic through phosphorylation of AMPK and increased expression of GLUT4 in type 2 diabetic model rats.

Authors:  Mohammad Asrafuzzaman; Mohammad M Rahman; Manoj Mandal; Mohammad Marjuque; Amrita Bhowmik; Begum Rokeya; Zahid Hassan; Mohammad Omar Faruque
Journal:  J Taibah Univ Med Sci       Date:  2018-08-09

9.  The biology of ergothioneine, an antioxidant nutraceutical.

Authors:  Irina Borodina; Louise C Kenny; Cathal M McCarthy; Kalaivani Paramasivan; Etheresia Pretorius; Timothy J Roberts; Steven A van der Hoek; Douglas B Kell
Journal:  Nutr Res Rev       Date:  2020-02-13       Impact factor: 7.800

Review 10.  Medicinal Mushrooms: Bioactive Compounds, Use, and Clinical Trials.

Authors:  Giuseppe Venturella; Valeria Ferraro; Fortunato Cirlincione; Maria Letizia Gargano
Journal:  Int J Mol Sci       Date:  2021-01-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.